SeaStar Medical Holding Corp Financing Cash Flow
SeaStar Medical Holding Corp (ICU) reported Financing Cash Flow of $734.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $605.00K, a 84.92% decline year-over-year.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $129.00K, a 97.90% decline year-over-year.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.31M, a 47.83% decline year-over-year.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $11.30M, a 91.45% increase year-over-year.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for fiscal 2025 was $23.76M, a 34.62% increase from fiscal 2024.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for fiscal 2024 was $17.65M, a 69.48% increase from fiscal 2023.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for fiscal 2023 was $10.41M, a 42.05% increase from fiscal 2022.
- SeaStar Medical Holding Corp net cash provided by (used in) financing activities for fiscal 2022 was $7.33M, a 160.24% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $734.00K 10-Q · filed 2026-08-12 | $3.04M derived: sum of 3 quarters · filed 2026-08-12 | $14.35M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2026-03-31 | $129.00K 10-Q · filed 2026-05-13 | $2.44M derived: sum of 2 quarters · filed 2026-05-13 | $13.74M derived: sum of 3 quarters · filed 2026-05-13 | $17.76M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $13.62M derived: sum of 2 quarters · filed 2026-03-25 | $17.63M derived: sum of 3 quarters · filed 2026-08-12 | $23.76M 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | $11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.32M derived: sum of 2 quarters · filed 2026-08-12 | $21.45M 10-Q · filed 2025-11-13 | $25.88M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $10.14M 10-Q · filed 2026-08-12 | $14.57M derived: sum of 3 quarters · filed 2026-08-12 | $20.48M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-03-31 | $6.13M 10-Q · filed 2026-05-13 | $10.56M derived: sum of 2 quarters · filed 2026-05-13 | $16.47M derived: sum of 3 quarters · filed 2026-05-13 | $15.45M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $10.34M derived: sum of 2 quarters · filed 2026-03-25 | $9.32M derived: sum of 3 quarters · filed 2026-03-25 | $17.65M 10-K · filed 2026-03-25 | |||||
| 2024-09-30 | $5.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.89M derived: sum of 2 quarters · filed 2025-11-13 | $13.22M 10-Q · filed 2025-11-13 | $17.81M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $7.32M 10-Q · filed 2025-08-13 | $11.90M derived: sum of 3 quarters · filed 2025-08-13 | $13.30M derived: sum of 4 quarters · filed 2025-08-13 | |||||
| 2024-03-31 | $8.33M 10-Q · filed 2025-05-14 | $12.92M derived: sum of 2 quarters · filed 2025-05-14 | $14.32M derived: sum of 3 quarters · filed 2025-05-14 | $15.77M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.99M derived: sum of 2 quarters · filed 2025-03-27 | $7.44M derived: sum of 3 quarters · filed 2025-03-27 | $10.41M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.85M derived: sum of 2 quarters · filed 2024-11-13 | $5.83M 10-Q · filed 2024-11-13 | $11.13M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.43M 10-Q · filed 2024-08-13 | $9.73M derived: sum of 3 quarters · filed 2024-08-13 | $10.08M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $2.97M 10-Q · filed 2024-05-14 | $8.27M derived: sum of 2 quarters · filed 2024-05-14 | $8.62M derived: sum of 3 quarters · filed 2024-05-14 | $10.02M derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $5.65M derived: sum of 2 quarters · filed 2024-04-16 | $7.05M derived: sum of 3 quarters · filed 2024-04-16 | $7.33M 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.75M derived: sum of 2 quarters · filed 2023-11-14 | $2.03M 10-Q · filed 2023-11-14 | $2.77M 10-Q · filed 2022-11-14 | -$101.23M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.68M 10-Q · filed 2023-08-14 | $911.94K 10-Q · filed 2022-08-16 | -$101.58M derived: sum of 3 quarters · filed 2023-08-14 | -$101.70M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $284.00K 10-Q · filed 2023-05-15 | $310.00K 10-Q · filed 2022-05-19 | -$102.98M derived: sum of 2 quarters · filed 2023-05-15 | -$103.09M derived: sum of 3 quarters · filed 2023-05-15 | -$103.21M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$103.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$103.38M derived: sum of 2 quarters · filed 2023-03-30 | -$103.50M derived: sum of 3 quarters · filed 2023-03-30 | $2.82M 10-K · filed 2023-03-30 | $106.75M 10-K · filed 2022-04-06 | ||||
| 2021-09-30 | -$116.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$236.95K derived: sum of 2 quarters · filed 2022-11-14 | $106.08M 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$120.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | $106.19M 10-Q · filed 2022-08-16 | |||||||
| 2021-03-31 | $106.32M 10-Q · filed 2022-05-19 | ||||||||
| 2020-12-31 | $151.41K 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |